Concepedia

Kei Miyakawa

KM

Statistics

Publications

45

Citations

1.8K

H-Index

22

Active since

1992

Affiliations

Yokohama City University(Current)

National Institute of Infectious Diseases

Life Science Institute

Kanto Chemical (Japan)

Yokohama City University Hospital

Kei Miyakawa is an author at Yokohama City University specializing in life sciences, molecular virology, and virology.

ORCID

Publications per year

1992–2022

45

Publications

45

Potent antiviral effect of silver nanoparticles on SARS-CoV-2

Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Takeshi Morita et al. · Biochemical and Biophysical Research Communications · 2020 · 431 citations · Full text

, , +13

Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells

Yunzhong Nie, Yun‐Wen Zheng, Kei Miyakawa et al. · EBioMedicine · 2018 · 179 citations · Full text

, , +17

HBx-induced degradation of Smc5/6 complex impairs homologous recombination-mediated repair of damaged DNA

Kazuma Sekiba, Motoyuki Otsuka, Kazuyoshi Funato et al. · Journal of Hepatology · 2021 · 101 citations · Full text

, , +17

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins

Kei Miyakawa, Mayuko Nishi, Michinaga Ogawa et al. · Nature Communications · 2022 · 83 citations · Full text

, , +17

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests

Yutaro Yamaoka, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah et al. · Cell Reports Medicine · 2021 · 54 citations · Full text

, , +17

1–5 of 45